Fujian Cosunter Pharmaceutical Balance Sheet Health
Financial Health criteria checks 1/6
Fujian Cosunter Pharmaceutical has a total shareholder equity of CN¥533.1M and total debt of CN¥436.6M, which brings its debt-to-equity ratio to 81.9%. Its total assets and total liabilities are CN¥1.5B and CN¥978.8M respectively.
Key information
81.9%
Debt to equity ratio
CN¥436.63m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥131.09m |
| Equity | CN¥533.12m |
| Total liabilities | CN¥978.75m |
| Total assets | CN¥1.51b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300436's short term assets (CN¥402.2M) do not cover its short term liabilities (CN¥522.8M).
Long Term Liabilities: 300436's short term assets (CN¥402.2M) do not cover its long term liabilities (CN¥455.9M).
Debt to Equity History and Analysis
Debt Level: 300436's net debt to equity ratio (57.3%) is considered high.
Reducing Debt: 300436's debt to equity ratio has increased from 24.9% to 81.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 300436 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 300436 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 24.3% each year